Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) Revenue (2017 - 2025)

Historic Revenue for Assembly Biosciences (ASMB) over the last 8 years, with Q3 2025 value amounting to $10.8 million.

  • Assembly Biosciences' Revenue rose 5761.87% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 3129.63%. This contributed to the annual value of $28.5 million for FY2024, which is 29815.72% up from last year.
  • Assembly Biosciences' Revenue amounted to $10.8 million in Q3 2025, which was up 5761.87% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Revenue ranged from a high of $10.8 million in Q3 2025 and a low of $5.8 million during Q1 2024
  • For the 4-year period, Assembly Biosciences' Revenue averaged around $8.0 million, with its median value being $7.4 million (2024).
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 8193.06% in 2021, then soared by 6281.76% in 2025.
  • Quarter analysis of 4 years shows Assembly Biosciences' Revenue stood at $6.3 million in 2021, then rose by 14.53% to $7.2 million in 2023, then increased by 2.71% to $7.4 million in 2024, then skyrocketed by 46.65% to $10.8 million in 2025.
  • Its Revenue stands at $10.8 million for Q3 2025, versus $9.6 million for Q2 2025 and $9.4 million for Q1 2025.